“Every Brilliant Thing” has recouped its Broadway capitalization. Duncan Macmillan and Jonny Donahoe’s now Tony Award-nominated play, which currently stars Daniel Radcliffe, cost $5.75 million to mount on Broadway. Lead producers Second Half Productions, Seaview and Gavin Kalin Productions announced today that it has earned this initial investment back.
Broadway’s “Every Brilliant Thing” has frequently performed well in weekly box office grosses since it officially opened on March 12, often appearing at or near the top of capacity and average paid admission rankings. The production was recently nominated for two Tony Awards: Best Performance by an Actor in a Leading Role in a Play for Radcliffe and Best Revival of a Play, for which it was deemed eligible, despite having never been performed on Broadway before, due to the Tonys’ “classics” rule.
The play’s limited engagement was recently extended through June 28. Radcliffe is set to depart the show on May 24, following which Emmy Award and Golden Globe Award winner and “Law & Order: Special Victims Unit” star Mariska Hargitay will join the production on May 26.
“Every Brilliant Thing” begins with a child who, after their mother’s suicide attempt, sets out to write a list of all the things worth living for. They continue the list throughout their lifetime, tracking an ever-changing perspective on happiness. The play, which is performed by a single actor with audience participation, is currently running at Broadway’s Hudson Theatre and is co-directed by Macmillan and Jeremy Herrin.
“Every Brilliant Thing” has also partnered with mental health nonprofits Project Healthy Minds, the Trevor Project and the American Foundation for Suicide Prevention, hosting a pair of talkbacks between Radcliffe and members of these organizations to raise awareness for their mental health outreach efforts.
